Skip to content
#protein folding Open access

Integrative transcriptomics–metabolomics reveals sphingolipid metabolic reprogramming in traditional Chinese medicine syndrome differentiation of rheumatoid arthritis

Sep 2026 · Frontiers in Immunology · 0 citations · 47 references

TL;DR

C17-sphinganine is a core metabolic biomarker for distinguishing kidney-liver deficiency syndrome from heat-dampness syndrome, enabling precise syndrome classification with a single measurement.

Abstract

To investigate sphingolipid metabolism for differentiating heat-dampness syndrome from kidney-liver deficiency syndrome in Rheumatoid Arthritis (RA), identify metabolic biomarkers, and integrate transcriptomic data to elucidate molecular mechanisms. 40 RA patients (kidney-liver deficiency syndrome, n=20; heat-dampness syndrome, n=20) were enrolled and serum untargeted metabolomics profiling was performed using ultra-performance liquid chromatography-tandem mass spectrometry. A least absolute shrinkage and selection operator logistic regression diagnostic model was constructed, and its performance was assessed by receiver operating characteristic curve and decision curve analyses. Three independent transcriptomic datasets were downloaded from the Gene Expression Omnibus database (GSE55235: 10 RA synovium, 10 osteoarthritis synovium, and 10 normal synovium; GSE93272: RA whole blood and healthy control whole blood; GSE17755: RA peripheral blood mononuclear cells and healthy control peripheral blood mononuclear cells), and differential expression and tissue-specific regulation of sphingolipid-metabolism-related genes were analyzed. Immune cell infiltration was estimated using marker gene set mean expression scoring, and Spearman correlation analysis was used to construct metabolite-clinical indicator networks. Sphingosine kinase 1 activity (sphingosine-1-phosphate/C17-sphinganine ratio) was significantly higher in the heat-dampness syndrome group than in the kidney-liver deficiency syndrome group (P = 3.45×10 -6 ). C17-sphinganine was significantly negatively correlated with sphingosine-1-phosphate (r = -0.555). C17-sphinganine alone distinguished kidney-liver deficiency syndrome from heat-dampness syndrome with an area under the curve of 0.945 and an accuracy of 95%. Sphingosine-1-phosphate lyase 1 was markedly upregulated in rheumatoid arthritis synovium compared with normal synovium (log2 fold change = 1.124, P = 2.17×10 -4 ) and also significantly upregulated in peripheral blood albeit with a smaller effect size (log 2 fold change = 0.134, P = 8.44×10 -4 ), demonstrating tissue-specific magnitude-difference regulation. Sphingosine kinase 1 showed a negative correlation trend with neutrophil infiltration. C8-ceramide-1-phosphate was negatively correlated with C-reactive protein (r = -0.47) and positively correlated with mean corpuscular hemoglobin (r = 0.51). C17-sphinganine is a core metabolic biomarker for distinguishing kidney-liver deficiency syndrome from heat-dampness syndrome, enabling precise syndrome classification with a single measurement. The tissue-specific magnitude-difference regulation of sphingosine-1-phosphate lyase 1 and the sphingosine kinase 1-neutrophil correlative trend provide novel insights into how sphingolipid metabolism participates in traditional Chinese medicine syndrome differentiation in RA.

Read PDF

Similar papers

Open access Aug 2026

Untargeted metabolomics reveals differential metabolic pathways and biomarkers in the acute phase of Kawasaki disease

Untargeted metabolomics enables identification of metabolically perturbed pathways during the acute phase of KD, and L-tyrosine, L-tryptophan, glutamine, histidine, histamine, and taurocholic acid may serve as candidate biomarkers for acute phase of KD.

Han-Qi Dai, Qian-Wen Wang, Yi Zhan · 0 citations
Open access Sep 2026

Integrated Multi-Tissue Omics Identifies Acylcarnitine Accumulation as Shared Metabolic Marker of Diabetic Microangiopathy With Cross-Organ Validation

A circulating carnitine/acylcarnitine signature may serve as a non-invasive indicator of microvascular risk, and the SLC22A5–CPT2 axis represents a potential therapeutic target.

Qian Liu, Yan Liu, Xiongyi Yang et al. · 0 citations
Aug 2026

Integrative transcriptomic and genetic analysis implicates fatty acid metabolic reprogramming in perivascular macrophages in Alzheimer’s disease

This integrative analysis prioritizes ACSL1, EPM2AIP1, MALT1, and RASGRP3 as candidate genes connecting fatty acid metabolic dysregulation with AD-associated neuroinflammatory processes, and supports a prioritized candidate framework for future functional testing.

Fan Wang, Xiangyang Wang, Yuhui Chen et al. · 0 citations
Open access Sep 2026

Integrative Transcriptomic Analysis and Functional Validation Implicate GPT2 in Glycolytic Regulation in Polycystic Ovary Syndrome

ABSTRACT Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine‐metabolic disorder characterized by profound disturbances in energy metabolism, yet the molecular mechanisms underlying glycolytic dysfunction remain incompletely understood. Given the essential role of glycolysis in ovarian function and endocrine h...

Mei-Li Xi, Rong-Kui Luo, Jiarong Zhang et al. · 0 citations
Open access Sep 2026

Integrated multi-omics analyses identify an RAS-SLC11A2-associated molecular framework linking iron metabolism with PCOS-related cardiometabolic risk.

This study defines an RAS-SLC11A2 molecular framework linking iron metabolism dysregulation to PCOS-related cardiometabolic risk, elucidating the mechanisms connecting ovarian dysfunction, inflammation, oxidative stress and hypertension, and supports gentiopicroside as a promising therapeutic candidate.

Si-Han Zhang, Yu Xu, Tingting Cao et al. · 0 citations
Open access Sep 2026

Integrated proteomic and metabolomic analyses define the molecular architecture of acute mountain sickness

A multi-layer molecular framework of human acute hypoxic stress is defined, linking vascular regulation, inflammation, coagulation, metabolic remodeling, tissue origin, and biomarker prioritization in hypoxia-associated systemic diseases.

Wen-Jing Ding, Yi-Fan Yang, Hua-Ying Wei et al. · 0 citations

Related blog posts

Google DeepMind Blog Sep 30, 2026

Introducing SynthID Bio

Proof of concept for watermarking AI-generated proteins while preserving biological function.

MIT News · Artificial Intelligence Aug 27, 2026

Looking beyond natural sequences

A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.